Fundraising Fox

Vincent Brichard

Investor

Venture Partner at EQT Life Sciences

Brussels

Writes $1M – $5M checks · typically $1.5M

About

Vincent Brichard is a Venture Partner at EQT Group, a European venture capital firm focused on biotechnology. With over a decade of professional experience, he specializes in clinical trials, oncology, and research and development strategy, supporting portfolio companies in clinical development and strategic initiatives.

Experience

  1. EQT GroupVenture Partnercurrent2015 — present
  2. VIANOVA srlFounder & CEOcurrent2014 — present
  3. Solvay Lifelong Learning | Solvay Brussels School of Economics & ManagementProfessor Advanced Master in Biotechnology - Solvaycurrent2022 — present
  4. Fournier-Majoie FoundationScientific & Investment Advisory Boardcurrent2015 — present
  5. atbtherapeuticsIndependent Board member2018 — 2024
  6. ethernaIndependent Board member2016 — 2022
  7. PARACRINE THERAPEUTICSCo-founder&CEO2019 — 2020
  8. ChromaCureChairman of the Board2018 — 2020
  9. Celyad OncologyVice-President Oncology2014 — 2015
  10. GlaxoSmithKline BiologicalsSenior Executive Vice President2002 — 2014GlaxoSmithKline Biologicals
  11. Harvard Business SchoolMBA2012
  12. Université catholique de LouvainProfessor of Oncology2000 — 2002
  13. Institut CurieMedical Oncology Department1998 — 2000
  14. Ludwig Cancer ResearchPHD1990 — 1996

Education

  1. Université catholique de LouvainMD, oncology1986 — 1990

Skills & more

Clinical Trials31Oncology61Biotechnology29Infectious Diseases14Vaccines29Immunology41Medicine18Clinical Development12Life Sciences13Market Access8Drug Development9Diabetes1
+2 moreBiopharmaceuticalsDrug Discovery

Languages English · French

From Vincent's professional profile.

Same school

Shared employers

Colleagues at EQT Life Sciences